Martin Dobson
About Martin Dobson
Martin Dobson is the Senior Director Commercial CEEG at BeiGene in Basel, Switzerland, with extensive experience in the pharmaceutical industry and a strong background in managing international markets and partnerships.
Title
Martin Dobson is the Senior Director of Commercial CEEG at BeiGene, based in Basel, Switzerland.
Professional Experience at BeiGene
Martin Dobson currently serves as the Senior Director of Commercial CEEG at BeiGene in Basel, Switzerland. His role involves overseeing commercial operations and strategic initiatives across the CEEG region, leveraging his extensive experience in the pharmaceutical industry.
Previous Roles at Jazz Pharmaceuticals
Before his current position, Martin worked at Jazz Pharmaceuticals as the Business Director for International and Partner Markets from 2020 to 2022. He operated from Oxford, England, managing international market strategies and partner relationships.
Career Journey at Celgene
Martin Dobson held significant roles at Celgene from 2015 to 2020. As Partner Liaison Director from 2015 to 2018, he managed partnerships in Emerging Markets, EMEA from Boudry, Switzerland. Later, he served as Account Director in the United Kingdom from 2018 to 2020, leading commercial strategies and account management.
Bristol-Myers Squibb Tenure
Martin has a long history with Bristol-Myers Squibb, where he worked for 21 years. He was the EU Distributor Markets Director from 2011 to 2015 in the United Kingdom, and previously the Head of Distribution and Pharmacy from 1994 to 2011. His roles encompassed responsibilities such as distribution management and pharmacy operations.
Education and Professional Expertise
Martin holds a B.Sc in Food Science and Management Studies from King's College London, completed between 1983 and 1986. He has demonstrated extensive expertise in multiple areas of the pharmaceutical industry, including commercial operations, international market management, and partner relationship management.
PhRMA MEA Executive Committee Role
Martin Dobson contributes to strategic decisions in the pharmaceutical industry through his position on the PhRMA MEA Executive Committee. His input supports the development and implementation of industry-wide policies and best practices.